Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma(Front. Oncol., (2022), 12, (963896), 10.3389/fonc.2022.963896)

Nguyen Van Hiep; Wei Lun Sun; Po Hao Feng; Cheng Wei Lin; Kuan Yuan Chen; Ching Shan Luo; Le Ngoc Dung; Hoang Van Quyet; Sheng Ming Wu; Kang Yun Lee

doi:10.3389/fonc.2022.1106553

Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma(Front. Oncol., (2022), 12, (963896), 10.3389/fonc.2022.963896)

Nguyen Van Hiep, Wei Lun Sun, Po Hao Feng, Cheng Wei Lin, Kuan Yuan Chen, Ching Shan Luo, Le Ngoc Dung, Hoang Van Quyet, Sheng Ming Wu, Kang Yun Lee

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

摘要

In the published article, there was an error in affiliation 1. Instead of “IInternational Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”, it should be “International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”.

原文	英語
文章編號	1106553
期刊	Frontiers in Oncology
卷	12
DOIs	https://doi.org/10.3389/fonc.2022.1106553
出版狀態	已發佈 - 12月 13 2022

ASJC Scopus subject areas

腫瘤科
癌症研究

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.3389/fonc.2022.1106553

其它文件與鏈接

指紋

深入研究「Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma(Front. Oncol., (2022), 12, (963896), 10.3389/fonc.2022.963896)」主題。共同形成了獨特的指紋。

引用此

Van Hiep, N., Sun, W. L., Feng, P. H., Lin, C. W., Chen, K. Y., Luo, C. S., Dung, L. N., Van Quyet, H., Wu, S. M., & Lee, K. Y. (2022). Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma(Front. Oncol., (2022), 12, (963896), 10.3389/fonc.2022.963896). Frontiers in Oncology, 12, [1106553]. https://doi.org/10.3389/fonc.2022.1106553

Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma(Front. Oncol., (2022), 12, (963896), 10.3389/fonc.2022.963896). / Van Hiep, Nguyen; Sun, Wei Lun; Feng, Po Hao 等.
於: Frontiers in Oncology, 卷 12, 1106553, 13.12.2022.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Van Hiep, N, Sun, WL, Feng, PH , Lin, CW , Chen, KY , Luo, CS, Dung, LN, Van Quyet, H, Wu, SM & Lee, KY 2022, 'Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma(Front. Oncol., (2022), 12, (963896), 10.3389/fonc.2022.963896)', Frontiers in Oncology, 卷 12, 1106553. https://doi.org/10.3389/fonc.2022.1106553

Van Hiep N, Sun WL, Feng PH , Lin CW , Chen KY , Luo CS 等. Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma(Front. Oncol., (2022), 12, (963896), 10.3389/fonc.2022.963896). Frontiers in Oncology. 2022 12月 13;12:1106553. doi: 10.3389/fonc.2022.1106553

@article{c3764aa4799646ccae5cd5c201d28204,

title = "Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma(Front. Oncol., (2022), 12, (963896), 10.3389/fonc.2022.963896)",

abstract = "In the published article, there was an error in affiliation 1. Instead of “IInternational Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”, it should be “International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”.",

keywords = "bioinformatics, biomarker, heparin-binding EGF-like growth factor (HBEGF), immune infiltration, macrophage chemotaxis, non-small cell lung cancer",

author = "{Van Hiep}, Nguyen and Sun, {Wei Lun} and Feng, {Po Hao} and Lin, {Cheng Wei} and Chen, {Kuan Yuan} and Luo, {Ching Shan} and Dung, {Le Ngoc} and {Van Quyet}, Hoang and Wu, {Sheng Ming} and Lee, {Kang Yun}",

note = "Publisher Copyright: {\textcopyright} 2022 Van Hiep, Sun, Feng, Lin, Chen, Luo, Dung, Van Quyet, Wu and Lee.",

year = "2022",

month = dec,

day = "13",

doi = "10.3389/fonc.2022.1106553",

language = "English",

volume = "12",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - Corrigendum

T2 - Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma(Front. Oncol., (2022), 12, (963896), 10.3389/fonc.2022.963896)

AU - Van Hiep, Nguyen

AU - Sun, Wei Lun

AU - Feng, Po Hao

AU - Lin, Cheng Wei

AU - Chen, Kuan Yuan

AU - Luo, Ching Shan

AU - Dung, Le Ngoc

AU - Van Quyet, Hoang

AU - Wu, Sheng Ming

AU - Lee, Kang Yun

PY - 2022/12/13

Y1 - 2022/12/13

N2 - In the published article, there was an error in affiliation 1. Instead of “IInternational Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”, it should be “International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”.

AB - In the published article, there was an error in affiliation 1. Instead of “IInternational Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”, it should be “International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”.

KW - bioinformatics

KW - biomarker

KW - heparin-binding EGF-like growth factor (HBEGF)

KW - immune infiltration

KW - macrophage chemotaxis

KW - non-small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=85145006553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85145006553&partnerID=8YFLogxK

U2 - 10.3389/fonc.2022.1106553

DO - 10.3389/fonc.2022.1106553

M3 - Comment/debate

AN - SCOPUS:85145006553

SN - 2234-943X

VL - 12

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 1106553

ER -